Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.

Lorenzetti, R., Zullo, A., Ridola, L., Diamanti, A., Laganà, B., Gatta, L., Migliore, A., Armuzzi, A., Hassan, C., Bruzzese, V., Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials, <<ANNALS OF MEDICINE>>, 2014; 46 (7): 547-554. [doi:10.3109/07853890.2014.941919] [http://hdl.handle.net/10807/64556]

Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials

Armuzzi, Alessandro;
2014

Abstract

Treatment with tumour necrosis factor antagonists (anti-TNF) has been recognized as a risk factor for tuberculosis (TB) reactivation. Our aim was to evaluate risk of TB reactivation in rheumatologic and non-rheumatologic diseases treated with the same anti-TNF agents with and without concomitant therapies.
2014
Inglese
Lorenzetti, R., Zullo, A., Ridola, L., Diamanti, A., Laganà, B., Gatta, L., Migliore, A., Armuzzi, A., Hassan, C., Bruzzese, V., Higher risk of tuberculosis reactivation when anti-TNF is combined with immunosuppressive agents: a systematic review of randomized controlled trials, <<ANNALS OF MEDICINE>>, 2014; 46 (7): 547-554. [doi:10.3109/07853890.2014.941919] [http://hdl.handle.net/10807/64556]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/64556
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 92
  • ???jsp.display-item.citation.isi??? 79
social impact